DNA copy number changes and evaluation of MYC, IGF1R, and FES amplification in xenografts of pancreatic adenocarcinoma

Cancer Genetics and Cytogenetics

Volumn 116, Issue 2, 2000, Pages 133-141

  Armengol, Gemma ^a   Knuutila, Sakari ^b   Lluís, Fèlix ^c   Capellà, Gabriel ^c   Miró, Rosa ^d   Caballín, Maria Rosa ^a  

^a Unitat d'Antropologia   (Spain)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTROMERE; CHROMOSOME ABERRATION; CHROMOSOME ARM; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; METASTASIS; NONHUMAN; ONCOGENE MYC; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT;

ADENOCARCINOMA; ADULT; AGED; ANIMALS; BLOTTING, SOUTHERN; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENES, MYC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; MALE; MICE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FES; RECEPTOR, IGF TYPE 1; TRANSPLANTATION, HETEROLOGOUS;

EID: 0033991993     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00118-1     Document Type: Article

References (39)

1. Niederhuber J.E., Brennan M.F., Menck H.R. The National Cancer Database report on pancreatic cancer. Cancer. 76:1995;1671-1677.
2. Hall PA, Lemoine NR (1993): Models of Pancreatic Cancer. Cancer Surveys, Vol. 16: The Molecular Pathology of Cancer. Imperial Cancer Research Fund, pp. 135-155.
3. Johansson B., Bardi G., Heim S., Mandahl N., Mertens F., Bak-Jensen E., Andrén-Sandberg A., Mitelman F. Nonrandom chromosomal rearrangements in pancreatic carcinoma. Cancer. 69:1992;1674-1681.
4. Bardi G., Johansson B., Pandis N., Mandahl N., Bak-Jensen E., Andren-Sandberg A., Mitelman F., Heim S. Karyotypic abnormalities in tumours of the pancreas. Br J Cancer. 67:1993;1106-1112.
5. Griffin C.A., Hruban R.H., Morsberger L.A., Ellingham T., Long P.P., Jaffee E.M., Hauda K.M., Bohlander S.K., Yeo C.J. Consistent chromosome abnormalities in adenocarcinoma of the pancreas. Cancer Res. 55:1995;2394-2399.
6. Gorunova L., Höglund M., Andrén-Sandberg A., Dawiskiba S., Jin Y., Mitelman F., Johansson B. Cytogenetic analysis of pancreatic carcinomas. intratumor heterogeneity and nonrandom pattern of chromosome aberrations Genes Chromosom Cancer. 23:1998;81-99.
7. Seymour A.B., Hruban R.H., Redston M.S., Caldas C., Powell S.M., Kinzler K.W., Yeo C.J., Kern S.E. Allelotype of pancreatic adenocarcinoma. Cancer Res. 54:1994;2761-2764.
8. Hahn S.A., Seymour A.B., Shamsul Hoque A.T.M., Schutte M., da Costa L.T., Redston M.S., Caldas C., Weinstein C.L., Fischer A., Yeo C.J., Hruban R.H., Kern S.E. Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res. 55:1995;4670-4675.
9. Hruban R.H., van Mansfeld A.D.M., Offerhaus G.J.A., van Weering D.H.J., Allison D.C., Goodman S.N., Kensler T.W., Bose K.K., Cameron J.L., Bos J.L. K-RAS oncogene activation in adenocarcinoma of the human pancreas. a study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization Am J Pathol. 143:1993;545-554.
10. Caldas C., Hahn S.A., daCosta L.T., Redston M.S., Schutte M., Seymour A.B., Weinstein C.L., Hruban R.H., Yeo C.J., Kern S.E. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet. 8:1994;27-32.
11. Reyes G., Villanueva A., García C., Sancho F.J., Piulats J., Lluís F., Capellà G. Orthotopic xenografts of human pancreatic carcinomas acquire genetic aberrations during dissemination in nude mice. Cancer Res. 56:1996;5713-5719.
12. Pellegata N.S., Sessa F., Renault B., Bonato M., Leone B., Solcia E., Ranzani G.N. K-RAS and P53 gene mutations in pancreatic cancer. ductal and nonductal tumors progress through different genetic lesions Cancer Res. 54:1994;1556-1560.
13. Redston M.S., Caldas C., Seymour A.B., Hruban R.H., da Costa L.T., Yeo C.J., Kern S.E. P53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res. 54:1994;3025-3033.
14. Hahn S.A., Hoque A.T., Moskaluk C.A., da Costa L.T., Schutte M., Rozenblum E., Seymour A.B., Weinstein C.L., Yeo C.J., Hruban R.H., Kern S.E. Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res. 56:1996;490-494.
15. Goggins M., Schutte M., Lu J., Moskaluk C.A., Weinstein C.L., Petersen G.M., Yeo C.J., Jackson C.E., Lynch H.T., Hruban R.H., Kern S.E. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. 56:1996;5360-5364.
16. Horii A., Nakatsuru S., Miyoshi Y., Ichii S., Nagase H., Ando H., Yanagisawa A., Tsuchiya E., Kato Y., Nakamura Y. Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res. 52:1992;6696-6698.
17. Höhne M.W., Halatsch M.E., Kahl G.F., Weinel R.J. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res. 52:1992;2616-2619.
18. Ruggeri B., Zhang S.-Y., Caamano J., DiRado M., Flynn S.D., Klein-Szanto A.J.P. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the P53 and RB-1 tumor-suppressor genes. Oncogene. 7:1992;1503-1511.
19. Knuutila S., Björkqvist A.-M., Autio K., Tarkkanen M., Wolf M., Monni O., Szymanska J., Larramendy M.L., Tapper J., Pere H., El-Rifai W., Hemmer S., Wasenius V.-M., Vidgren V., Zhu Y. DNA copy number amplifications in human neoplasms. review of comparative genomic hybridization studies Am J Pathol. 152:1998;1107-1123.
20. Solinas-Toldo S., Wallrapp C., Müller-Pillasch F., Bentz M., Gress T., Lichter P. Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. Cancer Res. 56:1996;3803-3807.
21. Fukushige S., Waldman F.M., Kimura M., Abe T., Furukawa T., Sunamura M., Kobari M., Horii A. Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma. Genes Chromosom Cancer. 19:1997;161-169.
22. Mahlamäki E.H., Höglund M., Gorunova L., Karhu R., Dawiskiba S., Andren-Sandberg A., Kallioniemi O.-P., Johansson B. Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer. Genes Chromosom Cancer. 20:1997;383-391.
23. Kallioniemi O.-P., Kallioniemi A., Piper J., Isola J., Waldman F.M., Gray J.W., Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer. 10:1994;231-243.
24. Forus A., Weghuis D.O., Smeets D., Fodstad O., Myklebost O., van Kessel A.G. Comparative genomic hybridization analysis of human sarcomas I. occurrence of genomic imbalances and identification of a novel major amplicon at 1q21~q22 in soft tissue sarcomas Genes Chromosom Cancer. 14:1995;8-14.
25. Forus A., Weghuis D.O., Smeets D., Fodstad O., Myklebost O., van Kessel A.G. Comparative genomic hybridization analysis of human sarcomas II. identification of novel amplicons at 6p and 17p in osteosarcomas Genes Chromosom Cancer. 14:1995;15-21.
26. Williams B.J., Jones E., Kozlowski J.M., Vessella R., Brothman A.R. Comparative genomic hybridization and molecular cytogenetic characterization of two prostate cancer xenografts. Genes Chromosom Cancer. 18:1997;299-304.
27. El-Rifai W., Harper J.C., Cummings O.W., Hyytinen E.R., Frierson H.F., Knuutila S., Powell S.M. Consistent genetic alterations in xenografts of proximal stomach and gastro-esophageal junction adenocarcinomas. Cancer Res. 58:1998;34-37.
28. Armengol G., Tarkkanen M., Virolainen M., Forus A., Valle J., Böhling T., Asko-Seljavaara S., Blomqvist C., Elomaa I., Karaharju E., Kivioja A.H., Siimes M.A., Tukiainen E., Caballín M.R., Myklebost O., Knuutila S. Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization. Br J Cancer. 75:1997;1403-1409.
29. Dib C., Fauré S., Fizames C., Samson D., Drouot N., Vignal A., Millasseau P., Marc S., Hazan J., Seboun E., Lathrop M., Gyapay G., Morissette J., Weissenbach J. A comprehensive genetic map of the human genome based on 5264 microsatellites. Nature. 380:1996;152-154.
30. Hyytinen E., Visakorpi T., Kallioniemi A., Kallionieme O.-P., Isola J. Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization. Cytometry. 16:1994;93-99.
31. Tanner M.M., Tirkkonen M., Kallioniemi A., Collins C., Stokke T., Karhu R., Kowbel D., Shadravan F., Hintz M., Kuo W.-L., Waldman F.M., Isola J.J., Gray J.W., Kallioniemi O.-P. Increased copy number at 20q13 in breast cancer. defining the critical region and exclusion of candidate genes Cancer Res. 54:1994;4257-4260.
32. Anzick S.L., Kononen J., Walker R.L., Azorsa D.O., Tanner M.M., Guan X.-Y., Sauter G., Kallioniemi O.-P., Trent J.M., Meltzer P.S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. 277:1997;965-968.
33. 32P-based hybridizations. Anal Biochem. 210:1993;235-244.
34. Ray M.E., Wistow G., Su Y.A., Meltzer P.S., Trent J.M. AIM1, a novel non-lens member of the β,γ-crystallin superfamily, is associated with the control of tumorigenicity in human malignant melanoma. Proc Natl Acad Sci USA. 94:1997;3229-3234.
35. Yamada H., Yoshida T., Sakamoto H., Terada M., Sugimura T. Establishment of a human pancreatic adenocarcinoma cell line (PSN-1) with amplifications of both C-MYC and activated C-KI-RAS by a point mutation. Biochem Biophys Res Commun. 140:1986;167-173.
36. Sakorafas G.H., Lazaris A., Tsiotou A.G., Koullias G., Glinatsis M.T., Golematis B.C. Oncogenes in cancer of the pancreas. Eur J Surg Oncol. 21:1995;251-253.
37. Tanner M., Tirkkonen M., Kallioniemi A., Isola J., Kuukasjärvi T., Collins C., Kowbel D., Guan X.-Y., Trent J., Gray J.W., Meltzer P., Kallioniemi O.-P. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res. 56:1996;3441-3445.
38. Sen S., Zhou H., White R.A. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene. 14:1997;2195-2200.
39. Höglund M., Gorunova L., Andren-Sandberg A., Dawiskiba S., Mitelman F., Johansson B. Cytogenetic and fluorescence in situ hybridization analyses of chromosome 19 aberrations in pancreatic carcinomas. frequent loss of 19p13.3 and gain of 19q13.1~13.2 Genes Chromosom Cancer. 21:1998;8-16.